Erratum to: Rapid early progression (REP) of glioblastoma is an independent negative prognostic factor: Results from a systematic review and meta-analysis
- PMID: 35958979
- PMCID: PMC9361735
- DOI: 10.1093/noajnl/vdac125
Erratum to: Rapid early progression (REP) of glioblastoma is an independent negative prognostic factor: Results from a systematic review and meta-analysis
Abstract
[This corrects the article DOI: 10.1093/noajnl/vdac075.].
© The Author(s) 2022. Published by Oxford University Press, the Society for Neuro-Oncology and the European Association of Neuro-Oncology.
Erratum for
-
Rapid early progression (REP) of glioblastoma is an independent negative prognostic factor: Results from a systematic review and meta-analysis.Neurooncol Adv. 2022 Jun 4;4(1):vdac075. doi: 10.1093/noajnl/vdac075. eCollection 2022 Jan-Dec. Neurooncol Adv. 2022. PMID: 35769410 Free PMC article.
Similar articles
-
Erratum to: Characterizing Benefit from Temozolomide in MGMT Promoter Unmethylated and Methylated Glioblastoma: A Systematic Review and Meta-analysis.Neurooncol Adv. 2021 Jul 10;3(1):vdab095. doi: 10.1093/noajnl/vdab095. eCollection 2021 Jan-Dec. Neurooncol Adv. 2021. PMID: 34258581 Free PMC article.
-
Erratum to: Lessons learned from contemporary glioblastoma randomized clinical trials through systematic review and network meta-analysis: part 1 newly diagnosed disease.Neurooncol Adv. 2021 Sep 1;3(1):vdab117. doi: 10.1093/noajnl/vdab117. eCollection 2021 Jan-Dec. Neurooncol Adv. 2021. PMID: 34485909 Free PMC article.
-
Rapid Early Tumor Progression is Prognostic in Glioblastoma Patients.Am J Clin Oncol. 2019 May;42(5):481-486. doi: 10.1097/COC.0000000000000537. Am J Clin Oncol. 2019. PMID: 30973372
-
Erratum to: Targeting the TREM1-positive myeloid microenvironment in glioblastoma.Neurooncol Adv. 2023 Jan 5;5(1):vdac189. doi: 10.1093/noajnl/vdac189. eCollection 2023 Jan-Dec. Neurooncol Adv. 2023. PMID: 36632568 Free PMC article.
-
Erratum to: Prognostic value of O 6-methylguanine-DNA methyltransferase methylation in isocitrate dehydrogenase mutant gliomas.Neurooncol Adv. 2022 Jun 2;4(1):vdac069. doi: 10.1093/noajnl/vdac069. eCollection 2022 Jan-Dec. Neurooncol Adv. 2022. PMID: 35669014 Free PMC article.
Publication types
LinkOut - more resources
Full Text Sources